BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

10287

524774

NGLFINE

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

NGL FINE CHEM LIMITED performance

Today’s low

Today’s high

₹ 1075.00 ₹ 1149.90
₹ 1093.90

52 week low

52 week high

₹ 957.00 ₹ 2777.95
₹ 1093.90

Open Price

₹ 1075.00

Prev. Close

₹ 1107.00

Volume (Shares)

866.00

Total traded value

₹ 9.47

Upper Circuit

₹ 1162.30

Lower Circuit

₹ 1051.70

info

NGL FINE CHEM LIMITED Share Price Update

As of the latest trading session, NGL FINE CHEM LIMITED share price is currently at ₹ 1090, which is down by ₹ -17.00 from its previous closing. Today, the stock has fluctuated between ₹ 1075.00 and ₹ 1149.90. Over the past year, NGL FINE CHEM LIMITED has achieved a return of -57.08 %. In the last month alone, the return has been -3.10 %. Read More...

NGL FINE CHEM LIMITED fundamentals


  • Market cap (Cr)

    673.40

  • P/E Ratio (TTM)

    22.62

  • Beta

    0.87

  • Book Value / share

    451.95

  • Return on equity

    15.78%

  • EPS (TTM)

    47.74

  • Dividend yield

    0.16%

  • Net profit/quarter (Cr)

    0.78

info icon alternate text
  • Market cap (Cr)

    667.22

  • P/E Ratio (TTM)

    22.62

  • Beta

    0.78

  • Book Value / share

    451.95

  • Return on equity

    15.78%

  • EPS (TTM)

    47.74

  • Dividend yield

    0.16%

  • Net profit/quarter (Cr)

    0.78

info icon alternate text

NGL FINE CHEM LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 86.83
Operating Expense 86.17
Net Profit 0.78
Net Profit Margin (%) 0.89
Earnings Per Share (EPS) 1.27
EBITDA 3.71
Effective Tax Rate (%) 3.70
Particulars SEP 2024 (Values in Cr)
Revenue 91.41
Operating Expense 83.41
Net Profit 10.04
Net Profit Margin (%) 10.98
Earnings Per Share (EPS) 16.26
EBITDA 16.05
Effective Tax Rate (%) 25.24
Particulars JUN 2024 (Values in Cr)
Revenue 88.03
Operating Expense 84.30
Net Profit 7.83
Net Profit Margin (%) 8.89
Earnings Per Share (EPS) 12.67
EBITDA 12.58
Effective Tax Rate (%) 21.80
Particulars MAR 2024 (Values in Cr)
Revenue 95.61
Operating Expense 85.53
Net Profit 10.85
Net Profit Margin (%) 11.34
Earnings Per Share (EPS) 17.56
EBITDA 16.76
Effective Tax Rate (%) 23.80
Particulars DEC 2023 (Values in Cr)
Revenue 84.81
Operating Expense 76.21
Net Profit 8.90
Net Profit Margin (%) 10.49
Earnings Per Share (EPS) 14.40
EBITDA 15.15
Effective Tax Rate (%) 30.46
Particulars MAR 2024 (Values in Cr)
Revenue 328.97
Operating Expense 294.16
Net Profit 38.52
Net Profit Margin (%) 11.70
Earnings Per Share (EPS) 62.35
EBITDA 60.20
Effective Tax Rate (%) 24.03
Particulars MAR 2023 (Values in Cr)
Revenue 275.05
Operating Expense 256.07
Net Profit 20.12
Net Profit Margin (%) 7.31
Earnings Per Share (EPS) 32.56
EBITDA 35.70
Effective Tax Rate (%) 24.36
Particulars MAR 2022 (Values in Cr)
Revenue 318.67
Operating Expense 262.33
Net Profit 52.25
Net Profit Margin (%) 16.39
Earnings Per Share (EPS) 84.57
EBITDA 78.20
Effective Tax Rate (%) 24.25
Particulars MAR 2021 (Values in Cr)
Revenue 255.21
Operating Expense 190.73
Net Profit 55.47
Net Profit Margin (%) 21.73
Earnings Per Share (EPS) 89.79
EBITDA 85.23
Effective Tax Rate (%) 27.01
Particulars MAR 2020 (Values in Cr)
Revenue 152.18
Operating Expense 141.16
Net Profit 10.60
Net Profit Margin (%) 6.96
Earnings Per Share (EPS) 17.16
EBITDA 23.87
Effective Tax Rate (%) 26.13
Particulars MAR 2024 (Values in Cr)
Book Value / Share 425.11
ROE % 17.03
ROCE % 20.16
Total Debt to Total Equity 0.14
EBITDA Margin 20.04
Particulars MAR 2023 (Values in Cr)
Book Value / Share 360.23
ROE % 9.63
ROCE % 11.83
Total Debt to Total Equity 0.15
EBITDA Margin 14.56
Particulars MAR 2022 (Values in Cr)
Book Value / Share 328.94
ROE % 27.90
ROCE % 33.46
Total Debt to Total Equity 0.13
EBITDA Margin 24.84
Particulars MAR 2021 (Values in Cr)
Book Value / Share 250.01
ROE % 44.76
ROCE % 52.66
Total Debt to Total Equity 0.18
EBITDA Margin 34.16
Particulars MAR 2020 (Values in Cr)
Book Value / Share 160.18
ROE % 10.13
ROCE % 13.54
Total Debt to Total Equity 0.29
EBITDA Margin 16.52
Particulars MAR 2024 (Values in Cr)
Book Value / Share 425.39
ROE % 15.78
ROCE % 18.73
Total Debt to Total Equity 0.14
EBITDA Margin 18.44
Particulars MAR 2023 (Values in Cr)
Book Value / Share 365.04
ROE % 9.31
ROCE % 11.37
Total Debt to Total Equity 0.14
EBITDA Margin 13.21
Particulars MAR 2022 (Values in Cr)
Book Value / Share 334.36
ROE % 28.87
ROCE % 34.27
Total Debt to Total Equity 0.13
EBITDA Margin 24.65
Particulars MAR 2021 (Values in Cr)
Book Value / Share 251.62
ROE % 43.22
ROCE % 51.07
Total Debt to Total Equity 0.17
EBITDA Margin 33.15
Particulars MAR 2020 (Values in Cr)
Book Value / Share 163.81
ROE % 12.51
ROCE % 15.21
Total Debt to Total Equity 0.29
EBITDA Margin 17.40
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.72
Total Assets 355.53
Total Liabilities 355.53
Total Equity 262.63
Share Outstanding 6178024
Price to Book Ratio 4.91
Return on Assets (%) 11.62
Return on Capital (%) 14
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 13.04
Total Assets 287.07
Total Liabilities 287.07
Total Equity 222.54
Share Outstanding 6178024
Price to Book Ratio 3.28
Return on Assets (%) 7.13
Return on Capital (%) 8.1
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.82
Total Assets 276.92
Total Liabilities 276.92
Total Equity 203.21
Share Outstanding 6178024
Price to Book Ratio 5.86
Return on Assets (%) 18.01
Return on Capital (%) 21.69
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 4.77
Total Assets 207.38
Total Liabilities 207.38
Total Equity 154.45
Share Outstanding 6178024
Price to Book Ratio 6.09
Return on Assets (%) 27.34
Return on Capital (%) 34.29
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 3.15
Total Assets 153.62
Total Liabilities 153.62
Total Equity 98.96
Share Outstanding 6178024
Price to Book Ratio 1.55
Return on Assets (%) 5.42
Return on Capital (%) 6.84
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.59
Total Assets 353.04
Total Liabilities 353.04
Total Equity 262.80
Share Outstanding 6178024
Price to Book Ratio 4.91
Return on Assets (%) 10.91
Return on Capital (%) 13.05
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 12.94
Total Assets 288.11
Total Liabilities 288.11
Total Equity 225.52
Share Outstanding 6178024
Price to Book Ratio 3.28
Return on Assets (%) 6.98
Return on Capital (%) 7.86
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.73
Total Assets 277.72
Total Liabilities 277.72
Total Equity 206.56
Share Outstanding 6178024
Price to Book Ratio 5.86
Return on Assets (%) 18.81
Return on Capital (%) 22.38
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 4.69
Total Assets 205.79
Total Liabilities 205.79
Total Equity 155.45
Share Outstanding 6178024
Price to Book Ratio 6.09
Return on Assets (%) 26.95
Return on Capital (%) 33.33
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 3.07
Total Assets 155.58
Total Liabilities 155.58
Total Equity 101.20
Share Outstanding 6178024
Price to Book Ratio 1.55
Return on Assets (%) 6.81
Return on Capital (%) 8.54
Particulars MAR 2024 (Values in Cr)
Net Income 54.41
Cash from Operations 33.56
Cash from Investing -26.81
Cash from Financing -1.08
Net change in Cash -7.43
Free Cash Flow 62.08
Particulars MAR 2023 (Values in Cr)
Net Income 27.36
Cash from Operations 42.15
Cash from Investing -27.02
Cash from Financing -1.08
Net change in Cash 7.18
Free Cash Flow 73.55
Particulars MAR 2022 (Values in Cr)
Net Income 66.59
Cash from Operations 30.52
Cash from Investing -14.20
Cash from Financing -1.08
Net change in Cash -1.45
Free Cash Flow 86.90
Particulars MAR 2021 (Values in Cr)
Net Income 77.58
Cash from Operations 48.22
Cash from Investing -24.56
Cash from Financing -1.08
Net change in Cash 1.70
Free Cash Flow 65.43
Particulars MAR 2020 (Values in Cr)
Net Income 12.09
Cash from Operations 24.20
Cash from Investing -19.55
Cash from Financing -1.30
Net change in Cash -0.39
Free Cash Flow 39.34
Particulars MAR 2024 (Values in Cr)
Net Income 50.70
Cash from Operations 23.32
Cash from Investing -17.49
Cash from Financing -1.08
Net change in Cash -7.43
Free Cash Flow 51.33
Particulars MAR 2023 (Values in Cr)
Net Income 26.59
Cash from Operations 38.36
Cash from Investing -23.61
Cash from Financing -1.08
Net change in Cash 7.18
Free Cash Flow 67.47
Particulars MAR 2022 (Values in Cr)
Net Income 68.97
Cash from Operations 29.41
Cash from Investing -13.00
Cash from Financing -1.08
Net change in Cash -1.39
Free Cash Flow 44.26
Particulars MAR 2021 (Values in Cr)
Net Income 75.99
Cash from Operations 47.10
Cash from Investing -23.78
Cash from Financing -1.08
Net change in Cash 1.70
Free Cash Flow 52.22
Particulars MAR 2020 (Values in Cr)
Net Income 14.35
Cash from Operations 23.37
Cash from Investing -18.78
Cash from Financing -1.30
Net change in Cash -0.46
Free Cash Flow 30.66
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 19.60 1.99 279.41 34.11 / 77.70
BLISS GVS PHARMA LTD 119.00 15.60 1.24 1253.91 92.25 / 184.95
CIPLA LTD 1549.65 25.08 4.41 125155.99 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 260.70 21.60 2.64 767.27 145.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 21.96 6.19 279.41 34.11 / 77.70
AMRUTAJAN HEALTH LTD 692.80 40.61 6.72 2002.93 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8665.50 129.24 31.88 21663.75 5000.00 / 9199.00
BLISS GVS PHARMA LTD 119.00 15.45 1.22 1253.91 92.25 / 184.95

NGL FINE CHEM LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
1093.90 -1.18 redarrow
red-green-graph indicator
15 Bearish
1 Bullish
  • 5 Days 1109.00
  • 26 Days 1118.10
  • 10 Days 1106.20
  • 50 Days 1194.90
  • 12 Days 1105.50
  • 100 Days 1387.20
  • 20 Days 1108.90
  • 200 Days 1636.00
1110.40 PIVOT

First Support

1081.80

First Resistance

1135.60

Second Support

1056.60

Second Resistance

1164.20

Third Support

1028.00

Third Resistance

1189.40

RSI

45.51

ADX

21.66

MACD

-12.65

Williams % R

-60.14

Commodity Channel Index (CCI)

18.96

Date

2025-02-20

Week

9030.00

Same Day

10726.00

Month

10609.00

1 Year

0.87

3 Year

0.77

Over 1 Month

-3.10%

down

Over 1 Year

-57.08%

down

Over 3 Months

-35.09%

down

Over 3 Years

-16.35%

down

Over 6 Months

-43.78%

down

Over 5 Years

0.00%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

NGL FINE CHEM LIMITED shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
27.26%
Promoter Holdings
72.73%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Rajesh Lawande 1352366.0 (21.89%) Shareholding of Promoter and Promoter Group
Rahul Nachane 1083450.0 (17.54%) Shareholding of Promoter and Promoter Group
Sunita Potdar 826510.0 (13.38%) Shareholding of Promoter and Promoter Group
Ajita Nachane 713449.0 (11.55%) Shareholding of Promoter and Promoter Group
Pci Ferrmone Chemicals (india) Pvt Ltd 517871.0 (8.38%) Shareholding of Promoter and Promoter Group
Yashkumar Poonamchand Golechha 65000.0 (1.05%) Public Shareholding
Yashkumar Poonamchand Golechha 65000.0 (1.05%) Public Shareholding
Pushpa Lawande 0.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

NGL FINE CHEM LIMITED corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
16 Aug 2024 1.75 Final 16 Aug 2024 Equity shares
18 Aug 2023 1.75 Final 18 Aug 2023 Equity shares
22 Jun 2022 1.75 Final 23 Jun 2022 Equity shares
12 Aug 2021 1.75 Final 13 Aug 2021 Equity shares
06 Aug 2020 1.75 Final 07 Aug 2020 Equity shares
13 Aug 2019 1.75 Final 16 Aug 2019 Equity shares
08 Aug 2007 0.5 Final 10 Aug 2007 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
18 Aug 2023 1.75 Final 18 Aug 2023 Equity shares
22 Jun 2022 1.75 Final 23 Jun 2022 Equity shares
12 Aug 2021 1.75 Final 13 Aug 2021 Equity shares
06 Aug 2020 1.75 Final 07 Aug 2020 Equity shares
13 Aug 2019 1.75 Final 16 Aug 2019 Equity shares
08 Aug 2007 0.5 Final 10 Aug 2007 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

NGL FINE CHEM LIMITED Share Price

NGL Fine-Chem Limited was incorporated on December 18, 1981 as a Private Limited Company in the State of Maharashtra. The Company became a Public Limited Company. The Company has got its registered office and factory at New Bombay. It was promoted by Mr. A.G.Lawande, Mr.R. J. Nachane joined Mr.A.G.Lawande for actively participating in the Management of the Company in 1989. The Company is a manufacturer of pharmaceuticals and intermediates for usage in veterinary and human health. It is presently engaged in chemical substances used in manufacture of pharmaceuticals and Allopathic medicines.

The Company had at its commencement set up manufacturing facilities for the manufacture of Chloroquire Phosphate (antimalarial) which has a very good market at that time. But in absence of rain-fall in severe drought conditions during 1985-86 there was a very low incidence of malaria and the demand for the drug came down drastically. This forced a price war in the industry which led to the company being hit badly, ultimately leading to losses.

During 1996-97, Company has faced illegal labor strike from October 1996. The Company is continuing operations by importing material and having it converted/processed from other units. The workers have been able to obtain an injunction from the labour court against the company which prevents the company from clearing any stocks from the factory.

The Company carried out refurbishment of the plant and commenced its manufacturing activities in 2000-01. In 2004-05, the Scheme of Amalgamation of Alpha Organics Private Limited and Konarak Textile Industries Private Limited with the Company became effective on 4th March 2005. Accordingly, the entire undertakings of Alpha Organics Private Limited and Konarak Textile Industries Private Limited was transferred to the Company with effect from 1st April 2004. Consequently, the Company allotted 31,78,024 Equity Shares of Rs. 5 each fully
paid up to the shareholders of both the Transferor Companies. Further under the same scheme, the existing capital of the Company
was reorganized. The Paid Up value of each share was reduced from Rs. 10 per share to Rs. 5 per share.

The Company's new manufacturing plant at Tarapur was commissioned during the year 2006. It acquired Macrotech Polychem Private Limited (Wholly owned Subsidiary) on 15th May, 2019.

During 2021-22, the Company commenced construction at new plant in Tarapur. Similarly, it commissioned the expansion at its subsidiary, Macrotech Polychem Private Limited in December, 2021.

Parent organization Indian Private
NSE symbol NGLFINE
Founded 1981
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of NGL Fine Chem Ltd?

Answer Field

The share price of NGL Fine Chem Ltd for NSE is ₹ 1090 and for BSE is ₹ 1080.

What is the Market Cap of NGL Fine Chem Ltd?

Answer Field

The market cap of NGL Fine Chem Ltd for NSE is ₹ 6,73.40 Cr. and for BSE is ₹ 6,67.22 Cr. as of now.

What is the 52 Week High and Low of NGL Fine Chem Ltd?

Answer Field

The 52 Week High and Low of NGL Fine Chem Ltd for NSE is ₹ 2777.95 and ₹ 957.00 and for BSE is ₹ 2774.40 and ₹ 962.70.

How to Buy NGL Fine Chem Ltd share?

Answer Field

You can trade in NGL Fine Chem Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for NGL Fine Chem Ltd?

Answer Field

The 1 year returns on the stock has been -57.08%.

What is the Current Share Price of NGL Fine Chem Ltd?

Answer Field

NGL Fine Chem Ltd share price is for NSE ₹ 1090 & for BSE ₹ 1080 as on Apr 30 2025 03:29 PM.

What is the Market Cap of NGL Fine Chem Ltd Share?

Answer Field

The market cap of NGL Fine Chem Ltd for NSE ₹ 6,73.40 & for BSE ₹ 6,67.22 as on Apr 30 2025 03:29 PM.

What is the P/E Ratio of NGL Fine Chem Ltd Share?

Answer Field

As on Apr 30 2025 03:29 PM the price-to-earnings (PE) ratio for NGL Fine Chem Ltd share is 22.62.

What is the PB ratio of NGL Fine Chem Ltd Share?

Answer Field

As on Apr 30 2025 03:29 PM, the price-to-book (PB) ratio for NGL Fine Chem Ltd share is 451.95.

How to Buy NGL Fine Chem Ltd Share?

Answer Field

You can trade in NGL Fine Chem Ltd shares with Bajaj Broking by opening a demat account.

How to Buy NGL Fine Chem Ltd Share on Bajaj Broking App?

Answer Field

To buy NGL Fine Chem Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “NGL Fine Chem Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|